TR199802305T2 - Yanaktan uygulama y�ntemi. - Google Patents

Yanaktan uygulama y�ntemi.

Info

Publication number
TR199802305T2
TR199802305T2 TR1998/02305T TR9802305T TR199802305T2 TR 199802305 T2 TR199802305 T2 TR 199802305T2 TR 1998/02305 T TR1998/02305 T TR 1998/02305T TR 9802305 T TR9802305 T TR 9802305T TR 199802305 T2 TR199802305 T2 TR 199802305T2
Authority
TR
Turkey
Prior art keywords
lozenge
application method
cheek
cheek application
invented
Prior art date
Application number
TR1998/02305T
Other languages
English (en)
Turkish (tr)
Inventor
Ventouras Kimon
Original Assignee
Norvartis Consumer Health S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Norvartis Consumer Health S.A. filed Critical Norvartis Consumer Health S.A.
Publication of TR199802305T2 publication Critical patent/TR199802305T2/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/12—Antidiuretics, e.g. drugs for diabetes insipidus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Hematology (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Pulmonology (AREA)
  • Obesity (AREA)
  • Pain & Pain Management (AREA)
  • Physiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Nutrition Science (AREA)
  • Zoology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Otolaryngology (AREA)
  • Anesthesiology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Psychiatry (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
TR1998/02305T 1996-05-13 1997-05-06 Yanaktan uygulama y�ntemi. TR199802305T2 (xx)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP96810303 1996-05-13

Publications (1)

Publication Number Publication Date
TR199802305T2 true TR199802305T2 (xx) 2002-06-21

Family

ID=8225608

Family Applications (1)

Application Number Title Priority Date Filing Date
TR1998/02305T TR199802305T2 (xx) 1996-05-13 1997-05-06 Yanaktan uygulama y�ntemi.

Country Status (21)

Country Link
US (1) US6183775B1 (fr)
EP (1) EP0906089B1 (fr)
JP (1) JP3707798B2 (fr)
CN (1) CN1159000C (fr)
AT (1) ATE247951T1 (fr)
AU (1) AU2891997A (fr)
BR (1) BR9709452B1 (fr)
CA (1) CA2251623C (fr)
CY (1) CY2497B1 (fr)
CZ (1) CZ298212B6 (fr)
DE (1) DE69724424T2 (fr)
DK (1) DK0906089T3 (fr)
ES (1) ES2206709T3 (fr)
HU (1) HU224035B1 (fr)
NO (1) NO321608B1 (fr)
PL (1) PL187242B1 (fr)
PT (1) PT906089E (fr)
RU (1) RU2192245C2 (fr)
TR (1) TR199802305T2 (fr)
WO (1) WO1997042941A2 (fr)
ZA (1) ZA974077B (fr)

Families Citing this family (104)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6344222B1 (en) 1998-09-03 2002-02-05 Jsr Llc Medicated chewing gum delivery system for nicotine
US6358060B2 (en) 1998-09-03 2002-03-19 Jsr Llc Two-stage transmucosal medicine delivery system for symptom relief
US6248760B1 (en) * 1999-04-14 2001-06-19 Paul C Wilhelmsen Tablet giving rapid release of nicotine for transmucosal administration
US8758400B2 (en) 2000-01-05 2014-06-24 Integrated Vascular Systems, Inc. Closure system and methods of use
EP1118321A1 (fr) * 2000-01-14 2001-07-25 Ucb, S.A. Compositions pharmaceutiques solides pour la libération contrôlée de substances actives
FR2803720B1 (fr) * 2000-01-18 2004-10-22 Roquette Freres Lozenges a base de dextrose et leur procede de fabrication
IL135061A0 (en) * 2000-03-14 2001-05-20 Ahron Jodaikin Strategic targeted fluoridation and chemical treatment of teeth
US20050175959A1 (en) * 2000-03-14 2005-08-11 Coll Partners Ltd. System for the controlled delivery of an active material to a dental site
US7179483B2 (en) * 2000-04-26 2007-02-20 Watson Pharmaceuticals, Inc. Compositions and methods for transdermal oxybutynin therapy
JP2004508092A (ja) 2000-09-08 2004-03-18 コールマン　ジェイムス　イー 外科用ステープラ
US6756051B1 (en) 2000-11-15 2004-06-29 Li-Lan H. Chen Bioadhesive, closed-cell foam film, sustained release, delivery devices and methods of making and using same
US6623510B2 (en) 2000-12-07 2003-09-23 Integrated Vascular Systems, Inc. Closure device and methods for making and using them
US8690910B2 (en) 2000-12-07 2014-04-08 Integrated Vascular Systems, Inc. Closure device and methods for making and using them
FR2823974B1 (fr) 2001-04-25 2004-10-15 Pf Medicament Pastille medicamenteuse a liberation lente du principe actif
SE0102197D0 (sv) * 2001-06-20 2001-06-20 Pharmacia Ab New product and use and manufacture thereof
MXPA03000985A (es) * 2001-07-27 2004-04-02 Yamanouchi Pharma Co Ltd Composicion que comprende particulas finas de liberacion sostenida para tabletas de desintegracion rapida en la cavidad bucal y metodo de fabricacion de la misma.
US8529807B2 (en) * 2002-01-17 2013-09-10 Lts Lohmann Therapie-Systeme Ag Method for neutralizing or recycling carrier materials for film-like coatings
US20030148818A1 (en) * 2002-01-18 2003-08-07 Myrhum Mark C. Golf club woods with wood club head having a selectable center of gravity and a selectable shaft
FR2834890B1 (fr) * 2002-01-23 2004-02-27 Servier Lab Composition pharmaceutique orodispersible d'agomelatine
US6749621B2 (en) 2002-02-21 2004-06-15 Integrated Vascular Systems, Inc. Sheath apparatus and methods for delivering a closure device
SE0201669D0 (sv) * 2002-06-03 2002-06-03 Pharmacia Ab New formulation and use thereof
DE10224612A1 (de) * 2002-06-04 2003-12-24 Lohmann Therapie Syst Lts Wirkstoffhaltige filmförmige Zubereitungen mit verbesserter chemischer Stabilität, und Verfahren zu deren Herstellung
CA2488688A1 (fr) 2002-06-04 2003-12-11 Christy Cummins Clip de fermeture pour vaisseau sanguin et dispositif d'apport
JP2004026725A (ja) * 2002-06-26 2004-01-29 Sunstar Inc 固形製剤
US20040052851A1 (en) * 2002-09-16 2004-03-18 Graff Allan H. Modified release oral dosage form
ES2209649B1 (es) * 2002-12-09 2005-03-16 Carlos Arana Molina (Titular Al 25%) Utilizacion de la melatonina para la higiene bucodental para uso humano y veterinario como producto activo.
DK1803443T3 (en) 2002-12-20 2019-02-25 Niconovum Ab Nicotine-containing particulate material with a crystalline cellulose
SE0302947D0 (sv) 2003-01-24 2003-11-07 Magle Ab A composition material for transmucosal delivery
SI1617823T1 (sl) * 2003-01-24 2019-07-31 Nicachet Ab Vrečka, ki obsega nikotinski sestavek za transmukozno dajanje
US8398656B2 (en) 2003-01-30 2013-03-19 Integrated Vascular Systems, Inc. Clip applier and methods of use
US8202293B2 (en) 2003-01-30 2012-06-19 Integrated Vascular Systems, Inc. Clip applier and methods of use
US20040151771A1 (en) * 2003-02-04 2004-08-05 Gin Jerry B. Long-lasting, flavored dosage forms for sustained release of beneficial agents within the mouth
IL155666A (en) * 2003-04-29 2013-12-31 Neurim Pharma 1991 Insomnia treatment
US9119846B2 (en) 2003-04-29 2015-09-01 Neurim Pharmaceuticals (1991) Ltd. Method and composition for enhancing cognition in alzheimer's patients
US7276246B2 (en) * 2003-05-09 2007-10-02 Cephalon, Inc. Dissolvable backing layer for use with a transmucosal delivery device
US7306812B2 (en) 2003-05-09 2007-12-11 Cephalon, Inc. Dissolvable backing layer for use with a transmucosal delivery device
PL2446881T3 (pl) * 2003-07-24 2014-08-29 Glaxosmithkline Llc Folie rozpuszczające się w jamie ustnej
US20060112965A1 (en) * 2003-08-11 2006-06-01 Whalen William F Chewing tobacco substitute containing cotinine
US20050034738A1 (en) * 2003-08-11 2005-02-17 Whalen William F. Chewing tobacco substitute containing nicotine
GB0320854D0 (en) 2003-09-05 2003-10-08 Arrow No 7 Ltd Buccal drug delivery
US20050065175A1 (en) * 2003-09-24 2005-03-24 Xanodyne Pharmacal, Inc. Oral transmucosal methadone
US20070191815A1 (en) 2004-09-13 2007-08-16 Chrono Therapeutics, Inc. Biosynchronous transdermal drug delivery
CN104397869B (zh) * 2003-11-07 2016-06-08 美国无烟烟草有限责任公司 烟草组合物
US8627828B2 (en) 2003-11-07 2014-01-14 U.S. Smokeless Tobacco Company Llc Tobacco compositions
US8252321B2 (en) 2004-09-13 2012-08-28 Chrono Therapeutics, Inc. Biosynchronous transdermal drug delivery for longevity, anti-aging, fatigue management, obesity, weight loss, weight management, delivery of nutraceuticals, and the treatment of hyperglycemia, alzheimer's disease, sleep disorders, parkinson's disease, aids, epilepsy, attention deficit disorder, nicotine addiction, cancer, headache and pain control, asthma, angina, hypertension, depression, cold, flu and the like
CN101262786B (zh) * 2005-05-25 2015-04-08 美国无烟烟草有限责任公司 烟草组合物
US8313497B2 (en) 2005-07-01 2012-11-20 Abbott Laboratories Clip applier and methods of use
JP2007210905A (ja) * 2006-02-07 2007-08-23 Asahi Breweries Ltd 口腔内用顆粒、錠剤およびその製造方法
CA2646942C (fr) 2006-03-16 2014-07-29 Modoral Brands Inc. Composition amelioree de tabac a priser
US8556930B2 (en) 2006-06-28 2013-10-15 Abbott Laboratories Vessel closure device
US7754234B2 (en) * 2006-07-12 2010-07-13 Jones Thomas L Composition and method of treating a sore throat
US8642016B2 (en) 2006-07-21 2014-02-04 Jsrnti, Llc Medicinal delivery system, and related methods
EP1891936A1 (fr) * 2006-08-18 2008-02-27 Losan Pharma GmbH Les compositions pharmaceutiques bien avalables qui ne causent pas une sensation orale désagréable et qui contiennent des particules avec un principe actif
US8889184B2 (en) 2006-09-07 2014-11-18 Losan Pharma Gmbh Particulate form of a pharmaceutical composition which is easy to swallow
PL2051693T3 (pl) * 2006-08-18 2011-04-29 Losan Pharma Gmbh Kompozycja farmaceutyczna, łatwa do połknięcia i nie powodująca nieprzyjemnych odczuć w ustach, zawierająca cząstki z substancją czynną
WO2008094877A2 (fr) * 2007-01-30 2008-08-07 Drugtech Corporation Compositions pour l'administration orale de produits pharmaceutiques
AU2008216867B2 (en) * 2007-02-09 2014-01-30 Durect Corporation Transoral dosage forms comprising sufentanil and naloxone
US20080286340A1 (en) * 2007-05-16 2008-11-20 Sven-Borje Andersson Buffered nicotine containing products
US20080286341A1 (en) * 2007-05-16 2008-11-20 Sven-Borje Andersson Buffered coated nicotine containing products
US7850453B2 (en) * 2007-08-08 2010-12-14 Coll Partners Ltd. Reshapable device for fixation at a dental site
EP2471516A3 (fr) 2007-09-14 2012-12-26 Wockhardt Limited Compositions de rhéine ou diacéréine
US20090081294A1 (en) * 2007-09-26 2009-03-26 Gin Jerry B Sustained release dosage form for lubricating an oral cavity
CL2009001025A1 (es) 2008-05-01 2010-09-24 Smithkline Beecham Corp Composicion de pastilla para chupar que comprende: a) un granulo patron con al menos: un agente tampon alcalino, un modificador de la disolucion y una carga, b) un principio activo de nicotina definido extragranular y al menos un agente tampon alcalino; procedimiento de preparacion; util para eliminar o reducir el uso de tabaco.
US9282965B2 (en) 2008-05-16 2016-03-15 Abbott Laboratories Apparatus and methods for engaging tissue
US9241696B2 (en) 2008-10-30 2016-01-26 Abbott Vascular Inc. Closure device
US9414820B2 (en) 2009-01-09 2016-08-16 Abbott Vascular Inc. Closure devices, systems, and methods
US20100179589A1 (en) * 2009-01-09 2010-07-15 Abbott Vascular Inc. Rapidly eroding anchor
US9486191B2 (en) 2009-01-09 2016-11-08 Abbott Vascular, Inc. Closure devices
US9173644B2 (en) 2009-01-09 2015-11-03 Abbott Vascular Inc. Closure devices, systems, and methods
US20100185234A1 (en) 2009-01-16 2010-07-22 Abbott Vascular Inc. Closure devices, systems, and methods
US20100256215A1 (en) * 2009-04-02 2010-10-07 Silver Eagle Labs Nv, Llc Menthol-Melatonin Dissolving Film
US20110054492A1 (en) 2009-08-26 2011-03-03 Abbott Laboratories Medical device for repairing a fistula
WO2011100643A1 (fr) * 2010-02-12 2011-08-18 Sensient Colors Inc. Compositions d'enrobage entérique et procédés de fabrication et d'utilisation de celui-ci
MX2012009586A (es) * 2010-02-18 2012-09-12 Jatin Vasant Thakkar Patillas de gelatina blanda con nicotina.
UA112974C2 (uk) 2010-09-16 2016-11-25 Джеі. Бі. Кемікалс Енд Фармасьютікалс Лімітид Нікотиновмісна композиція (варіанти)
LT3284459T (lt) 2011-04-29 2021-04-12 Moberg Pharma Ab Farmacinės kompozicijos, apimančios vietinį anestetiką, tokį kaip bupivakainas, skirtos vietiniam įvedimui į burną arba gerklę
US20130017259A1 (en) 2011-07-06 2013-01-17 The Parkinson's Institute Compositions and Methods for Treatment of Symptoms in Parkinson's Disease Patients
FR2978916B1 (fr) * 2011-08-10 2013-07-26 Servier Lab Composition pharmaceutique solide pour administration buccale d'agomelatine
US20130078307A1 (en) 2011-09-22 2013-03-28 Niconovum Usa, Inc. Nicotine-containing pharmaceutical composition
US9474303B2 (en) 2011-09-22 2016-10-25 R.J. Reynolds Tobacco Company Translucent smokeless tobacco product
US9084439B2 (en) 2011-09-22 2015-07-21 R.J. Reynolds Tobacco Company Translucent smokeless tobacco product
US9629392B2 (en) 2011-09-22 2017-04-25 R.J. Reynolds Tobacco Company Translucent smokeless tobacco product
US9332976B2 (en) 2011-11-30 2016-05-10 Abbott Cardiovascular Systems, Inc. Tissue closure device
US20130177646A1 (en) * 2012-01-05 2013-07-11 Mcneil Ab Solid Nicotine-Comprising Dosage Form with Reduced Organoleptic Disturbance
US9763928B2 (en) 2012-02-10 2017-09-19 Niconovum Usa, Inc. Multi-layer nicotine-containing pharmaceutical composition
US9044035B2 (en) 2012-04-17 2015-06-02 R.J. Reynolds Tobacco Company Remelted ingestible products
US9456916B2 (en) 2013-03-12 2016-10-04 Medibotics Llc Device for selectively reducing absorption of unhealthy food
FR2993778B1 (fr) * 2012-07-30 2016-06-17 Pf Medicament Pastilles a cinetiques multiples de liberation de principes actifs
US9364209B2 (en) 2012-12-21 2016-06-14 Abbott Cardiovascular Systems, Inc. Articulating suturing device
US9067070B2 (en) 2013-03-12 2015-06-30 Medibotics Llc Dysgeusia-inducing neurostimulation for modifying consumption of a selected nutrient type
US9011365B2 (en) 2013-03-12 2015-04-21 Medibotics Llc Adjustable gastrointestinal bifurcation (AGB) for reduced absorption of unhealthy food
AR096223A1 (es) 2013-05-10 2015-12-16 Glaxosmithkline Llc Pastilla de nicotina para administración oral
US9668844B2 (en) 2013-11-06 2017-06-06 Colldent Y.A Ltd Device for fixation at a dental site
WO2016123406A1 (fr) 2015-01-28 2016-08-04 Chrono Therapeutics Inc. Procédés et systèmes d'administration de médicament
EP3267875A4 (fr) 2015-03-12 2018-12-05 Chrono Therapeutics Inc. Système d'entrée d'état de manque et de support
WO2018129304A1 (fr) 2017-01-06 2018-07-12 Chrono Therapeutics Inc. Dispositifs et methodes d'administration transdermique de medicament
CA3101966A1 (fr) 2018-05-29 2019-12-05 Morningside Venture Investments Limited Procedes et systemes d'administration de medicament
US12397141B2 (en) 2018-11-16 2025-08-26 Morningside Venture Investments Limited Thermally regulated transdermal drug delivery system
WO2020136620A1 (fr) 2018-12-29 2020-07-02 3M Innovative Properties Company Articles oraux et leurs procédés d'utilisation
WO2020136606A1 (fr) 2018-12-29 2020-07-02 3M Innovative Properties Company Article buccaux et procédés d'utilisation
PL3946262T3 (pl) * 2019-08-30 2024-11-25 Evie Sa Wypełnione granulki, sposób ich wytwarzania i ich zastosowania
US20210106516A1 (en) * 2019-10-11 2021-04-15 Fertin Pharma A/S Ion-Exchange Composition With Water-Soluble Mucoadhesive Polymers
CN113208156B (zh) * 2021-05-07 2022-08-12 云南中烟工业有限责任公司 一种基于柠檬酸尼古丁盐胶凝剂的载香超分子凝胶
WO2026022532A1 (fr) * 2024-07-22 2026-01-29 Aavishkar Oral Strips Pvt Ltd Film oral de nicotine et son procédé de préparation

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4206209A (en) 1978-11-02 1980-06-03 Kracauer Paul Sublingual aspirin tablet
CA1208558A (fr) 1982-10-07 1986-07-29 Kazuo Kigasawa Medicament oral
GB8317576D0 (en) 1983-06-29 1983-08-03 Shaw A S W Consumer tobacco products
LU85058A1 (fr) * 1983-10-24 1985-06-19 Pharlyse Comprimes pharmaceutiques a liberation prolongee,leur preparation et leur utilisation
US4680323A (en) * 1983-12-01 1987-07-14 Hans Lowey Method and composition for the preparation of controlled long-acting pharmaceuticals for oral administration
BE899037A (fr) 1984-02-29 1984-06-18 Trenker Ady Composition a sucer permettant de cesser de fumer
US4863737A (en) 1985-05-01 1989-09-05 University Of Utah Compositions and methods of manufacture of compressed powder medicaments
US5288497A (en) 1985-05-01 1994-02-22 The University Of Utah Compositions of oral dissolvable medicaments
GB8615676D0 (en) 1986-06-26 1986-07-30 Stoppers Co Ltd Nicotine containing lozenge
IL85538A (en) * 1987-02-27 1991-09-16 Lilly Co Eli Sustained release matrix tablet formulations containing hydrophilic and enteric polymers
KR960011236B1 (ko) * 1987-05-08 1996-08-21 스미스 클라인 앤드 프렌취 라보라토리스 리미티드 제약학적 조성물 및 고체 제형
GB8928196D0 (en) 1989-12-13 1990-02-14 Merrell Dow Pharmaceuticals Li Pharmaceutical lozenges
SE8904295D0 (sv) 1989-12-21 1989-12-21 Pharmacia Ab Smoking substitute
GB9111224D0 (en) 1991-05-24 1991-07-17 Charwell Consumer Prod Smoking substitute preparation
ATE172637T1 (de) * 1991-12-24 1998-11-15 Yamanouchi Pharma Co Ltd Intrabukkal desintegrierende zubereitung und ihre herstellung
FR2699074B1 (fr) 1992-12-11 1995-03-03 Georges Grimberg Procédé d'obtention d'un médicament se présentant sous la forme d'un produit comprimé pouvant être avalé, sucé, croqué, délité.
US5496541C1 (en) * 1993-01-19 2001-06-26 Squigle Inc Tasteful toothpaste and other dental products
US5549906A (en) 1993-07-26 1996-08-27 Pharmacia Ab Nicotine lozenge and therapeutic method for smoking cessation
US5362496A (en) 1993-08-04 1994-11-08 Pharmetrix Corporation Method and therapeutic system for smoking cessation
DE4333190C2 (de) 1993-09-29 1996-05-30 Korsatko Werner Univ Prof Dr E Zerbeißtablette mit verzögerter Wirkstoff-Freisetzung
MA23587A1 (fr) * 1994-06-23 1995-12-31 Procter & Gamble Traitement du besoin en nicotine et/ou du syndrome de manque lie au tabagisme

Also Published As

Publication number Publication date
WO1997042941A2 (fr) 1997-11-20
DE69724424T2 (de) 2004-06-24
WO1997042941A3 (fr) 1997-12-24
BR9709452A (pt) 1999-08-10
ZA974077B (en) 1997-11-24
HU224035B1 (hu) 2005-05-30
EP0906089B1 (fr) 2003-08-27
BR9709452B1 (pt) 2008-11-18
HUP9903658A3 (en) 2000-04-28
NO321608B1 (no) 2006-06-12
CA2251623A1 (fr) 1997-11-20
NO984773D0 (no) 1998-10-13
RU2192245C2 (ru) 2002-11-10
US6183775B1 (en) 2001-02-06
PL329744A1 (en) 1999-04-12
CY2497B1 (en) 2005-09-02
NO984773L (no) 1998-10-13
CN1159000C (zh) 2004-07-28
JP3707798B2 (ja) 2005-10-19
CN1218395A (zh) 1999-06-02
PL187242B1 (pl) 2004-06-30
ATE247951T1 (de) 2003-09-15
DE69724424D1 (de) 2003-10-02
HK1019199A1 (en) 2000-01-28
PT906089E (pt) 2004-01-30
HUP9903658A2 (hu) 2000-03-28
CZ365998A3 (cs) 1999-02-17
DK0906089T3 (da) 2003-12-08
CA2251623C (fr) 2006-12-19
AU2891997A (en) 1997-12-05
EP0906089A2 (fr) 1999-04-07
JP2000504028A (ja) 2000-04-04
CZ298212B6 (cs) 2007-07-25
ES2206709T3 (es) 2004-05-16

Similar Documents

Publication Publication Date Title
WO1997042941A3 (fr) Systeme de liberation gingivo-jugal
UA37201C2 (uk) Композиція, що сприяє зниженню потреби людини у палінні тютюну, спосіб, що сприяє зниженню потреби людини у палінні тютюну (варіанти), та спосіб заміни паління тютюну (варіанти)
TR200003666T2 (tr) Akut bir astım vakasının önlenmesi , tedavisi için formoterol
DE69727922D1 (de) Schnell zerfallende orale dosierungsform
TR200002855T2 (tr) Raloksifenin solunum yolu ile veya burundan uygulanması.
DE69009185D1 (de) Arzneimittelfreisetzungssystem aus glucan und adjuvant.
BG106030A (en) Pharmaceutical composition
ZA931470B (en) A pharmaceutical composition containing a defined lipid system.
EP0841936A4 (fr) Compositions d'agents therapeutiques de conjugaison stabilises, formulation d'administration et de diagnostic les contenant
HUT73651A (en) Silicone grafted thermoplastic elastomeric copolymers and hair and skin care compositions containing the same
DK1137409T3 (da) Præparater og fremgangsmåde til lindring af human kvindelig seksuel dysfunktion
ATE460921T1 (de) Medikamenthaltige zusammensetzung in aerosolform
WO2000038626A3 (fr) Composition de substrat et procede d'utilisation associe, aux fins de sequestration de substances irritantes pour la peau
DE69922822D1 (de) Rekombinante haarbehandlungsmittel
IL127918A0 (en) Novel amino sugar and related sugar derivatives of indolylopyrrolocarbazoles their use as antitumor agents and pharmaceutical formulations
UA35611C2 (uk) Композиція місцевого застосування для інгібування росту волос у ссавців, спосіб із її використанням та композиція місцевого застосування для доставки водорозчинного фармакологічного засобу до шкіри
ATE209504T1 (de) Pharmazeutische zusammensetzungen enthaltent ein superoxyddismutase
WO2000039280A8 (fr) Procedes et composition de melanges naturels extremement purifies d'interferons de type i derives des leucocytes
SE9603725D0 (sv) New teatment
TR199801452T2 (xx) Jinekolojik rahats�zl�klar�n tedavisinde kullan�lan LHRH analoglar� ve anti�strojenlerden m�te�ekkil farmakolojik kombine madde.
HUP9902415A2 (hu) Azonnal felszabaduló szilárd beadási formák és eljárás azok előállítására
UA37278C2 (uk) Протикашльова фармацевтична композиція для перорального введення
ATE353224T1 (de) Abgabeeinrichtung für eine zusammensetzung einer pharmazeutisch wirksamen substanz
YU45103A (sh) Upotreba sarp/1 za lečenje i prevenciju skleroderme
NO970178D0 (no) Terpenoidderivater (sarcodictyiner) som er nyttige som antitumormidler